aducanumab   Click here for help

GtoPdb Ligand ID: 8325

Synonyms: aducanumab-avwa | Aduhelm® | BART | BIIB-037 | BIIB037
Approved drug
aducanumab is an approved drug (FDA (2021))
Compound class: Antibody
Comment: Aducanumab is a fully human IgG1-kappa monoclonal antibody directed against the amyloid beta (Aβ) found in the amyloid plaques in the brain tissue of patients with Alzheimer's disease (AD).
Peptide sequences and structural information about this antibody are available from its IMGT/mAb-DB record. A patent search reveals Biogen Idec's patent submission WO2014089500 [2].
Classification Click here for help
Compound class Antibody
Approved drug? Yes (FDA (2021))
International Nonproprietary Names Click here for help
INN number INN
9838 aducanumab
Synonyms Click here for help
aducanumab-avwa | Aduhelm® | BART | BIIB-037 | BIIB037
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 479
Other databases
GtoPdb PubChem SID 252166537
Search PubMed clinical trials aducanumab
Search PubMed titles aducanumab
Search PubMed titles/abstracts aducanumab
Wikipedia Aducanumab